Deltex Medical Group plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DTXMF research report →
About the company
Deltex Medical Group plc, with its global presence encompassing the United Kingdom, the United States, Spain, and Canada, is dedicated to the development, marketing, and distribution of its TrueVue brand of esophageal Doppler hemodynamic monitoring systems. The company's innovative product lineup features: Esophageal Doppler Probes: These probes are engineered to accurately gauge a patient's central vascular blood flow and fluid status by continuously measuring real-time blood velocities within the descending aorta. Loops plots: This technology provides dynamic visualization of aortic blood flow velocity and aortic blood pressure, tracked meticulously with every single heartbeat.
- CEO
- Natalie Emilia Wettler
- IPO
- 2009
- Employees
- 24
- HQ
- Chichester, GB
Price Chart
- Market Cap
- $180.58M
- P/E
- -0.22
- P/S
- 0.37
- P/B
- 0.09
- EV/EBITDA
- -1.88
- Div Yield
- 0.00%
- Gross Margin
- 63.34%
- Op Margin
- -59.23%
- Net Margin
- -72.18%
- ROE
- -45.48%
- ROIC
- -19.24%
- Revenue
- $2.06M · 15.77%
- Net Income
- $-1,797,000 · -40.17%
- EPS
- $-0.00 · 18.18%
- Op Income
- $-1,586,000
- FCF YoY
- 68.69%
- 52W High
- $0.10
- 52W Low
- $0.00
- 50D MA
- $0.10
- 200D MA
- $0.10
- Beta
- -2.39
- Avg Volume
- 34.98K
Get TickerSpark's AI analysis on DTXMF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our DTXMF coverage
Recent articles, reports, and earnings notes.
No research on DTXMF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DTXMF report →Similar companies
Peers in the same neighborhood.